Abstract
Impulse control disorders (ICDs) related to Parkinson’s disease (PD) have been increasingly recognized since the initial descriptions more than a decade ago. While some of the initial descriptions of compulsive gambling, buying, sexual behavior, and eating were quite spectacular, awareness by both the patient/family and health-care communities has led to earlier recognition and management and fewer consequences. In addition to these behaviors, others include punding (stereotyped, repetitive, purposeless behaviors), compulsive medication use, or the dopamine dysregulation syndrome (DDS), and, more recently, the dopamine agonist withdrawal syndrome (DAWS) has been recognized and defined. Risk factors for these behaviors have included the use of dopamine agonists (DAs), male sex, younger age, a history of ICDs, and a personal or family history of substance abuse, bipolar disorder, or gambling problems. This chapter will review current and potential future strategies for the management of these psychiatric symptoms in the setting of PD. The case described is an extremely challenging clinical array of initial resistance to therapy and then dependence on dopamine replacement on the background of anxiety and depression. The 9-year history of her care is intended to illustrate the subtleties of this syndrome. Early, straightforward descriptions of addictive behaviors are referenced for further reading.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease. Neurology. 2003;61:422–3.
Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in Parkinson’s disease. Mov Disord. 2009;24:1561–70.
Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science. 2007;318(5854):1309–12.
Napier TC, Corvol JC, Grace AA, Roitman JD, Rowe J, Voon V, Strafella AP. Linking neuroscience with modern concepts of impulse control disorders in Parkinson’s disease. Mov Disord. 2015;30(2):141–9.
Ricciardi L, Espay KJ, Krikorian R, Fasano A, Espay AJ. Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson’s disease. Parkinsonism Relat Disord. 2016;28:152–4.
Samuel M, Rodriguez-Oroz M, Antonini A, Brotchie JM, Ray Chaudhuri K, Brown RG, Galpern WR, Nirenberg MJ, Okun MS, Lang AE. Management of impulse control disorders in Parkinson’s disease: controversies and future approaches. Mov Disord. 2015;30(2):150–9.
Vela L, Martínez Castrillo JC, García Ruiz P, Gasca-Salas C, Macías Macías Y, Pérez Fernández E, Ybot I, Lopez Valdés E, Kurtis MM, Posada Rodriguez IJ, Mata M, Ruiz Huete C, Eimil M, Borrue C, Del Val J, López-Manzanares L, Rojo Sebastian A, Marasescu R. The high prevalence of impulse control behaviors in patients with early-onset Parkinson’s disease: a cross-sectional multicenter study. J Neurol Sci. 2016;368:150–4.
Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE. Impulse control disorders in Parkinson’s disease: a cross-sectional study of dopaminergic therapy and other clinical features in 3,090 patients. Arch Neurol. 2010;67:589–95.
Weintraub D, David AS, Evans AH, Grant JE, Stacy M. Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord. 2015;30:121–7.
Weintraub D, Papay K, Xie SX. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 2015;84(13):1386–7.
Wingo TS, Evatt M, Scott B, Freeman A, Stacy M. Impulse control disorders arising in three patients treated with rotigotine. Clin Neuropharmacol. 2009;32:59–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Stacy, M. (2019). Treatment of Dopamine Dysregulation Syndrome and Impulse Control Disorders in Parkinson’s Disease. In: Reich, S., Factor, S. (eds) Therapy of Movement Disorders. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-319-97897-0_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-97897-0_30
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-319-97896-3
Online ISBN: 978-3-319-97897-0
eBook Packages: MedicineMedicine (R0)